Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis

被引：24

作者：

Favalli, EG ^{[1
]}

Arreghini, M ^{[1
]}

Arnoldi, C ^{[1
]}

Panni, B ^{[1
]}

Marchesoni, A ^{[1
]}

Tosi, S ^{[1
]}

Pontikaki, I ^{[1
]}

机构：

[1] Gaetano Pini Inst, Ctr Rheumat Children, Milan, Italy

来源：

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2004年 / 51卷 / 02期

关键词：

D O I：

10.1002/art.20242

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：301 / 302

页数：2

共 8 条

[1] Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].

Braun, J ;

Brandt, J ;

Listing, J ;

Zink, A ;

Alten, R ;

Golder, W ;

Gromica-Ihle, E ;

Kellner, H ;

Krause, A ;

Schneider, M ;

Sörensen, H ;

Zeidler, H ;

Thriene, W ;

Sieper, J .

LANCET, 2002, 359 (9313) :1187-1193

[2] Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis [J].

Breuil, V ;

Brocq, O ;

Pellegrino, C ;

Grimaud, A ;

Euller-Ziegler, L .

ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (03) :199-200

[3]

CALIN A, 1994, J RHEUMATOL, V21, P2281

[4] Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α [J].

Gorman, JD ;

Sack, KE ;

Davis, JC .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18) :1349-1356

[5]

JENKINSON TR, 1994, J RHEUMATOL, V21, P1694

[6] A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis [J].

Maksymowych, WP ;

Jhangri, GS ;

Fitzgerald, AA ;

LeClercq, S ;

Chiu, P ;

Yan, A ;

Skeith, KJ ;

Aaron, SL ;

Homik, J ;

Davis, P ;

Sholter, D ;

Russell, AS .

ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :766-773

[7]

SHERGY W, 2002, ANN RHEUM DIS S1, V61, P178

[8]

van der Heijde D, 1999, J RHEUMATOL, V26, P951

← 1 →